chlorzoxazone has been researched along with Weight Loss in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emery, MG | 1 |
| Fisher, JM | 1 |
| Chien, JY | 1 |
| Kharasch, ED | 1 |
| Dellinger, EP | 1 |
| Kowdley, KV | 1 |
| Thummel, KE | 1 |
1 other study available for chlorzoxazone and Weight Loss
| Article | Year |
|---|---|
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Topics: Blood Glucose; Chlorzoxazone; Cytochrome P-450 CYP2E1; Enzyme Activation; Fatty Liver; Female; Gastr | 2003 |